BG Klinikum Bergmannstrost Halle gGmbH
- Address
- lock Available on a paid plan
Musculoskeletal Diseases and Nervous System Diseases
At BG Klinikum Bergmannstrost Halle gGmbH, research in these areas focuses on conditions affecting the spine and nervous system, with studies looking at ways to ease pain, support recovery, and improve function for people with serious injuries and chronic degeneration.
- Chronic low back pain linked to lumbar degenerative disc disease
- Acute incomplete cervical spinal cord injury
- Testing new treatments aimed at pain relief, neurological recovery, and better daily functioning
The site is also involved in evaluating therapies that may help restore disc health and support patients after spinal cord injury.
Respiratory Tract Diseases
Clinical trial activity in Respiratory Tract Diseases centers on severe lung injury, with research designed to improve breathing support, reduce inflammation, and speed recovery in critically ill patients.
- Acute Respiratory Distress Syndrome
- Evaluating whether an added therapy can improve lung function and shorten time on mechanical ventilation
- Studying inflammatory markers linked to severe respiratory illness
This work reflects a strong interest in treatments for life-threatening respiratory complications in hospital settings.
Skin and Connective Tissue Diseases
Research in Skin and Connective Tissue Diseases at this hospital includes studies for major burn injuries, with the goal of improving wound closure and limiting long-term scarring.
- Deep partial and full-thickness burns
- Comparing advanced skin repair approaches with standard grafting care
- Focusing on healing, skin restoration, and cosmetic and functional outcomes
These trials aim to support better recovery after severe skin damage and reduce the burden of burn-related complications.
Nervous System Diseases and rehabilitation-focused care
The Zentrum fuer Rueckenmarkverletzte also contributes to studies in brain injury, exploring whether new supportive therapies can improve safety and recovery after moderate to severe trauma to the brain.
- Subacute moderate to severe traumatic brain injury
- Assessing treatment safety and tolerability in neurological recovery
- Investigating options that may help improve outcomes after serious head injury
Overall, the site’s research highlights a broad commitment to challenging neurological, respiratory, musculoskeletal, and burn-related conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Dompe' Farmaceutici S.p.A.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Dompe' Farmaceutici S.p.A.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in BG Klinikum Bergmannstrost Halle gGmbH
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized Study of Andexanet Alfa Compared to Usual Care in Patients Receiving a Factor Xa Inhibitor who Require Urgent Surgery or Procedure (ANNEXA-RS) | AstraZeneca AB | Phase III | Not Recruiting | — | Jun 2024 |
IMP list
lock Showing 1 of 17 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aminocaproic Acid | 1 | Unknown | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.